Innovation Lifecycle Management: Health Technology Assessment (HTA)

By completely disclosing ambiguity, health technology assessments (HTAs) attempt to assist avoid clinical, social, financial, and ethical errors. To the array of choices for numerical assumptions than to quantify uncertainty for “qualitative” hypotheses, uncertainty analyses may address the former while overlooking the latter. Patent exclusivity, as well as various components of the administrative and HTA systems, currently do a poor job of rewarding and driving innovation. However, enhanced integration of the evidence expectations of various HTA and insurance bodies, as well as, to the extent possible, integration of HTA/coverage bodies’ expectations with the prerequisites of regulatory authorities, could have a strong positive influence on value-based health-care innovations. Therefore, importance of possible HTA enhancements is hence, emphasized.

Know anyone building innovative solutions that belong in this  'Health Technology Assessment (HTA)'?

Topic Community Insights

Total: 0 Product: 0 Solution: 0 Service: 0 News: 0 Events: 0

Related Topic Community


    Innovation Lifecycle Management: Health Technology Assessment (HTA) Topic Insights

    info

    Are there any products that should be added for evaluation? Click here to add/suggest.

    Medigy Innovation Network

    Connecting innovation decision makers to authoritative information, institutions, people and insights.

    Medigy Logo

    The latest News, Insights & Events

    Medigy accurately delivers healthcare and technology information, news and insight from around the world.

    The best products, services & solutions

    Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


    © 2023 Netspective Media LLC. All Rights Reserved.

    Built on Dec 8, 2023 at 12:54pm